AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35979259 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae I-3856
Number of subjects: 456
Study 32875658 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotigotine 3 mg per day for 6 weeks
Number of subjects: 70
Study 32875658 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 70
Study 35999352 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 0
Study 35999352 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody crizanlizumab
Number of subjects: 0
Study 35999352 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-glucose cotransporter-2 inhibitors
Number of subjects: 0
Study 35999352 — intervention group
Group type: EXPERIMENTAL
Intervention: Purinergic signaling receptor Y12 inhibitors
Number of subjects: 0
Study 35999352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34795191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance therapy based on the Satir Model and group psychological intervention
Number of subjects: 62
Study 34795191 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 32756081 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined multiprofessional education program
Number of subjects: 12
Study 32756081 — intervention group
Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 12
Study 35144974 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 80 mg orally three times a day for 14 days
Number of subjects: 55
Study 35144974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 35144974 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 55
Study 35144974 — intervention group
Group type: COMPARATOR
Intervention: Famotidine and Placebo
Number of subjects: 55
Study 34116637 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-octyl cyanoacrylate glue (Dermabond®)
Number of subjects: 30
Study 34116637 — intervention group
Group type: COMPARATOR
Intervention: Sterile strips
Number of subjects: 30
Study 32379766 — intervention group
Group type: EXPERIMENTAL
Intervention: Hidden conditioning
Number of subjects: 87
Study 32379766 — intervention group
Group type: EXPERIMENTAL
Intervention: Open conditioning
Number of subjects: 87
Study 32379766 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 87
Study 36273430 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifamily therapy (MFT) - 24 sessions in addition to treatment as usual (TAU)
Number of subjects: 55
Study 36273430 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) - individual and family sessions
Number of subjects: 55
Study 33380182 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic TKA
Number of subjects: 30
Study 33380182 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 30
Study 32383337 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy-related deaths
Number of subjects: 536233
Study 32383337 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of maternal deaths
Number of subjects: 536233
Study 32383337 — intervention group
Group type: EXPERIMENTAL
Intervention: Age distribution of maternal deaths
Number of subjects: 536233
Study 32383337 — intervention group
Group type: COMPARATOR
Intervention: Association with obstetric resources
Number of subjects: 536233
Study 36417403 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 29
Study 32743951 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiometabolic monitoring practices
Number of subjects: 228
Study 32743951 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurement
Number of subjects: 228
Study 32743951 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist circumference measurement
Number of subjects: 228
Study 32743951 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with recommended cardiometabolic monitoring
Number of subjects: 228
Study 32743951 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical associations
Number of subjects: 228
Study 36305925 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BT) injected into the smile muscle locations 15 days before surgery
Number of subjects: 18
Study 36305925 — intervention group
Group type: COMPARATOR
Intervention: Lip repositioning surgery only (Control group)
Number of subjects: 18
Study 33481822 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Enough Parenting program
Number of subjects: 55
Study 32333714 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal hydrogel spacer
Number of subjects: 380
Study 32333714 — intervention group
Group type: COMPARATOR
Intervention: Control (no rectal hydrogel spacer)
Number of subjects: 380
Study 34366208 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal packing
Number of subjects: 30
Study 34366208 — intervention group
Group type: COMPARATOR
Intervention: No packing
Number of subjects: 30
Study 33853701 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation for Schizophrenia (RECOS)
Number of subjects: 79
Study 33853701 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 79
Study 35122485 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 22
Study 35122485 — intervention group
Group type: COMPARATOR
Intervention: Sham-extracorporeal shock wave therapy (sham-ESWT)
Number of subjects: 22
Study 34775718 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote 'Internet+' interaction mode
Number of subjects: 394
Study 34775718 — intervention group
Group type: COMPARATOR
Intervention: Traditional blood pressure control mode
Number of subjects: 394
Study 32807727 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone suppression with docetaxel
Number of subjects: 0
Study 32807727 — intervention group
Group type: COMPARATOR
Intervention: Testosterone suppression without docetaxel
Number of subjects: 0
Study 35765022 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation with 37 °C constant temperature saline
Number of subjects: 110
Study 35765022 — intervention group
Group type: COMPARATOR
Intervention: Room temperature irrigation (Control)
Number of subjects: 110
Study 32214297 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with ketorolac (DEX group)
Number of subjects: 60
Study 32214297 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil combined with ketorolac (SUF group)
Number of subjects: 60
Study 35770540 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular ASP needles treatment
Number of subjects: 80
Study 35770540 — intervention group
Group type: COMPARATOR
Intervention: Routine treatments (Control)
Number of subjects: 80
Study 32952015 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumen-protected methionine (RPM)
Number of subjects: 74
Study 32952015 — intervention group
Group type: EXPERIMENTAL
Intervention: HMTBa
Number of subjects: 74
Study 32952015 — intervention group
Group type: EXPERIMENTAL
Intervention: HMBi
Number of subjects: 74
Study 32952015 — intervention group
Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 74
Study 35242730 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin treatment (four biannual rounds)
Number of subjects: 0
Study 35242730 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin treatment (two biannual rounds)
Number of subjects: 0
Study 35242730 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 0
Study 35682140 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast Strength Training (CST)
Number of subjects: 31
Study 35682140 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 31
Study 33950544 — intervention group
Group type: EXPERIMENTAL
Intervention: Tea Tree Oil (10% solution, 5 mL)
Number of subjects: 112
Study 33950544 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (83% ethanol, 2 mL)
Number of subjects: 112
Study 33950544 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium Chloride (0.8 mL)
Number of subjects: 112
Study 33950544 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 112
Study 32475274 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acid supplementation (9 g daily)
Number of subjects: 60
Study 32475274 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose powder, 9 g daily)
Number of subjects: 60
Study 34597713 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS with ranibizumab 100 mg/ml with fixed 24‐week refill‐exchanges (PDS Q24W)
Number of subjects: 418
Study 34597713 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal ranibizumab 0.5‐mg injections every 4 weeks (monthly ranibizumab)
Number of subjects: 418
Study 34067795 — intervention group
Group type: EXPERIMENTAL
Intervention: Matcha
Number of subjects: 0
Study 34067795 — intervention group
Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 0
Study 32381807 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1% curcumin, 1% hyaluronidase, and 0.1% triamcinolone acetonide
Number of subjects: 120
Study 32381807 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone and hyaluronidase mucoadhesive semisolid gel
Number of subjects: 120
Study 32381807 — intervention group
Group type: COMPARATOR
Intervention: 1% curcumin
Number of subjects: 120
Study 32381807 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone-hyaluronidase group
Number of subjects: 120
Study 36303197 — intervention group
Group type: EXPERIMENTAL
Intervention: Affinos® impregnated with platelet-rich plasma
Number of subjects: 0
Study 36303197 — intervention group
Group type: COMPARATOR
Intervention: Affinos® alone (control)
Number of subjects: 0
Study 33894363 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 300
Study 33894363 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl
Number of subjects: 300
Study 33274542 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus Paclitaxel
Number of subjects: 78
Study 33274542 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 78
Study 32741659 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid IMT measured after 18 months of intervention in the CIMT trial
Number of subjects: 230
Study 32741659 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline carotid IMT and CV risk factors (age, sex, baseline systolic blood pressure)
Number of subjects: 230
Study 32741659 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid IMT
Number of subjects: 230
Study 36244200 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency rTMS over right DLPFC
Number of subjects: 60
Study 36244200 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency rTMS over right OFC
Number of subjects: 60
Study 36244200 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60
Study 34797287 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise (TC) added to sodium hyaluronate treatment
Number of subjects: 146
Study 34797287 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate (control)
Number of subjects: 146
Study 32165316 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventolin® Evohaler® with verbal inhaler technique counselling (VC)
Number of subjects: 16
Study 32165316 — intervention group
Group type: COMPARATOR
Intervention: Ventolin® Evohaler® connected to Able Spacer® (AS)
Number of subjects: 16
Study 36175588 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA) 60 mg/kg/day for 3 days (D1-D3) followed by oral etoposide 50 mg once daily for two weeks (D4-D17)
Number of subjects: 27
Study 36175588 — intervention group
Group type: COMPARATOR
Intervention: Oral etoposide (historical control)
Number of subjects: 27
Study 34501728 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral quadratus lumborum block type I with 24 mL 0.375% ropivacaine
Number of subjects: 60
Study 34501728 — intervention group
Group type: COMPARATOR
Intervention: No block (control group)
Number of subjects: 60
Study 35120491 — intervention group
Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 153
Study 35120491 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclampsia cases
Number of subjects: 153
Study 35120491 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe preeclampsia/eclampsia cases
Number of subjects: 153
Study 35120491 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 153
Study 34309117 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy (PORT)
Number of subjects: 172
Study 34309117 — intervention group
Group type: COMPARATOR
Intervention: Postoperative concurrent chemoradiotherapy (POCRT)
Number of subjects: 172
Study 34309117 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery alone (SA)
Number of subjects: 172
Study 32337864 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D HD camera
Number of subjects: 30
Study 32337864 — intervention group
Group type: COMPARATOR
Intervention: 2D HD camera
Number of subjects: 30
Study 35491560 — intervention group
Group type: EXPERIMENTAL
Intervention: Warmed intravenous fluids (WIVF)
Number of subjects: 105
Study 35491560 — intervention group
Group type: COMPARATOR
Intervention: Routine care using a cotton blanket (Control)
Number of subjects: 105
Study 33596909 — intervention group
Group type: EXPERIMENTAL
Intervention: C2HEST score
Number of subjects: 2202
Study 32536320 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive VR therapeutic intervention
Number of subjects: 90
Study 35410317 — intervention group
Group type: EXPERIMENTAL
Intervention: Two synbiotics
Number of subjects: 600
Study 35410317 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 600
Study 35410317 — intervention group
Group type: COMPARATOR
Intervention: No supplement (Control)
Number of subjects: 600
Study 33839450 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive perampanel oral suspension
Number of subjects: 115
Study 36094318 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtuo
Number of subjects: 9957
Study 36094318 — intervention group
Group type: COMPARATOR
Intervention: Bactec FX
Number of subjects: 9957
Study 36094318 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtuo (aerobic bottles)
Number of subjects: 9957
Study 36094318 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtuo (all bottles)
Number of subjects: 9957
Study 34398412 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia crowns
Number of subjects: 60
Study 34398412 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium disilicate crowns
Number of subjects: 60
Study 34398412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast metal crowns
Number of subjects: 60
Study 32343004 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected adolescents (STEM gifted)
Number of subjects: 2234
Study 32343004 — intervention group
Group type: COMPARATOR
Intervention: Unselected adolescents
Number of subjects: 2234
Study 36002106 — intervention group
Group type: COMPARATOR
Intervention: Real-world (RW) group with single-unit UCB
Number of subjects: 278
Study 36002106 — intervention group
Group type: COMPARATOR
Intervention: Real-world (RW) group
Number of subjects: 278
Study 36002106 — intervention group
Group type: COMPARATOR
Intervention: Conditioning regimen (fludarabine 75 mg/m2, total body irradiation 12 Gy, cyclophosphamide 120 mg/kg)
Number of subjects: 278
Study 36002106 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplantation strategy failure
Number of subjects: 278
Study 33503193 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose conjugated estrogen (CE) 0.3 mg
Number of subjects: 73
Study 33503193 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 73
Study 33503193 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (Raloxifene + Low-dose CE)
Number of subjects: 73
Study 33503193 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 73
Study 32723723 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT intervention via mobile phone messaging robot; twice-daily messages for 2 weeks post-surgery.
Number of subjects: 82
Study 32723723 — intervention group
Group type: COMPARATOR
Intervention: Control group; received no messages.
Number of subjects: 82
Study 35132308 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-use therapeutic foods (RUTF1, RUTF2, RUTF3) formulated from maize grains, pulses (soybeans), and cooking banana fruits.
Number of subjects: 0
Study 34459077 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented cognitive behavioral therapy (CBT) adjunctive to treatment as usual (TAU)
Number of subjects: 80
Study 34459077 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 80
Study 34969009 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Nordic Hamstring Exercise with a platform angle of 40° (N40U)
Number of subjects: 14
Study 34969009 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral Nordic Hamstring Exercise with a platform angle of 50° (N50U)
Number of subjects: 14
Study 34969009 — intervention group
Group type: COMPARATOR
Intervention: Bilateral Nordic Hamstring Exercise with a platform angle of 40° (N40)
Number of subjects: 14
Study 32078096 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary tirofiban
Number of subjects: 208
Study 32078096 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tirofiban
Number of subjects: 208
Study 34474487 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy (O2)
Number of subjects: 55000
Study 34474487 — intervention group
Group type: EXPERIMENTAL
Intervention: Target oxygen saturation recommendations
Number of subjects: 55000
Study 32920968 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic surgery (RG)
Number of subjects: 116
Study 32920968 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery (LG)
Number of subjects: 116
Study 35169036 — intervention group
Group type: COMPARATOR
Intervention: Iberdomide (0.3 mg every other day, 0.3 mg once daily, 0.6 mg and 0.3 mg alternating once daily, or 0.6 mg once daily)
Number of subjects: 42
Study 35169036 — intervention group
Group type: COMPARATOR
Intervention: Iberdomide
Number of subjects: 42
Study 35169036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34393001 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized nutritional intervention program (individual, collective, and telephone recall)
Number of subjects: 75
Study 34393001 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control group)
Number of subjects: 75
Study 34393001 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized nutritional intervention program
Number of subjects: 75
Study 32819393 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF3 (3-mg∙kg-1 of caffeine)
Number of subjects: 20
Study 32819393 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF6 (6-mg∙kg-1 of caffeine)
Number of subjects: 20
Study 32819393 — intervention group
Group type: COMPARATOR
Intervention: PLA (non-caffeinated placebo)
Number of subjects: 20
Study 32819393 — intervention group
Group type: COMPARATOR
Intervention: CON (no supplement)
Number of subjects: 20
Study 32819393 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 20
Study 35750730 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental home visits (DHVs) every six months for 24 months
Number of subjects: 327
Study 35750730 — intervention group
Group type: COMPARATOR
Intervention: Educational leaflets only (Control Group)
Number of subjects: 327
Study 33560390 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine plus cytarabine (FLUGA)
Number of subjects: 283
Study 33560390 — intervention group
Group type: COMPARATOR
Intervention: 5-azacitidine
Number of subjects: 283
Study 35484921 — intervention group
Group type: EXPERIMENTAL
Intervention: Gong meditation (7 sessions, 50-60 minutes each)
Number of subjects: 80
Study 35484921 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 33895833 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-reduction intervention (group 1)
Number of subjects: 133
Study 33895833 — intervention group
Group type: COMPARATOR
Intervention: Usual care (group 2)
Number of subjects: 133
Study 35869943 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate titrated intravenous oxytocin infusion and early amniotomy
Number of subjects: 232
Study 35869943 — intervention group
Group type: COMPARATOR
Intervention: Delayed amniotomy after 4 hours of oxytocin
Number of subjects: 232
Study 33430647 — intervention group
Group type: EXPERIMENTAL
Intervention: MFG delivery by parent peers
Number of subjects: 180
Study 33430647 — intervention group
Group type: EXPERIMENTAL
Intervention: MFG delivery by School Health Education Program (SHEP) coordinators
Number of subjects: 180
Study 33430647 — intervention group
Group type: COMPARATOR
Intervention: Intervention with mental health wellness materials and educational supports
Number of subjects: 180
Study 35753926 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU/day)
Number of subjects: 2423
Study 35753926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2423
Study 34759152 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil gelatinase-associated lipocalin (NGL)
Number of subjects: 132
Study 34759152 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutrophil/Lymphocyte (N/L) ratio
Number of subjects: 132
Study 34759152 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy pregnant women)
Number of subjects: 132
Study 32061508 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 39
Study 32061508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 35757837 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart glasses
Number of subjects: 68
Study 35757837 — intervention group
Group type: COMPARATOR
Intervention: Manual counting
Number of subjects: 68
Study 33108442 — intervention group
Group type: EXPERIMENTAL
Intervention: Older anesthesiologists
Number of subjects: 300
Study 33108442 — intervention group
Group type: EXPERIMENTAL
Intervention: Female anesthesiologists
Number of subjects: 300